Dollars for Docs
How Industry Dollars Reach Your Doctors
JEFFREY T JENSEN
Listed Specialty: Obstetrics & Gynecology
3181 SW SAM JACKSON PARK RD, DEPT OB/GYN, UHN-70, OHSU, PORTLAND, OR, 97239-3011
JEFFREY JENSEN,
Yearly Payment Breakdown:
All Payments: At a Glance
2016
9
payments
$4,722
payment total
1
company paid this doctor
2015
15
payments
$5,648
payment total
2
companies paid this doctor
2014
21
payments
$21,452
payment total
4
companies paid this doctor
2013
36
payments
$15,315
payment total
4
companies paid this doctor
Payment Calendar in
This doctor received a payment on days in .
Each box below represents a single day during the disclosure period. A gray box indicates no payments. The darker the color, the more payments a doctor received that day.
Types of Payments in
| Category | Payments | Payment Value |
|---|---|---|
Consulting |
5 | $11,550 |
Consulting |
3 | $7,860 |
Honoraria |
2 | $7,050 |
Consulting |
3 | $4,050 |
Honoraria |
1 | $3,600 |
Travel and Lodging |
16 | $3,184 |
Consulting |
1 | $2,925 |
Travel and Lodging |
7 | $2,277 |
Travel and Lodging |
4 | $1,552 |
Travel and Lodging |
5 | $1,322 |
Food and Beverage |
16 | $671 |
Food and Beverage |
7 | $576 |
Food and Beverage |
7 | $276 |
Food and Beverage |
4 | $245 |
Drugs & Devices in
Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.
This physician does not have any payments relating to a specific drug or device for this year.
| Product Name | Product Type | Payments† |
|---|---|---|
NEXPLANON |
drug |
$3,150 |
OTHER |
drug |
$2,431 |
ESSURE |
device |
$67 |
| † May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products. | ||
| Product Name | Product Type | Payments† |
|---|---|---|
PARAGARD |
drug |
$8,637 |
ELAGOLIX |
drug |
$5,355 |
OTHER |
drug |
$5,000 |
NEXPLANON |
drug |
$1,400 |
NUVARING |
drug |
$1,050 |
REPRODUCTIVE HEALTH |
device |
$11 |
| † May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products. | ||
| Product Name | Product Type | Payments† |
|---|---|---|
NEXPLANON WOMEN'S HEALTH |
drug |
$5,450 |
FOLLISTIM AQ WOMEN'S HEALTH |
drug |
$5,450 |
NUVARING WOMEN'S HEALTH |
drug |
$5,450 |
LECETTE |
drug |
$4,629 |
NATAZIA |
drug |
$2,712 |
ELAGOLIX |
drug |
$1,412 |
NUVARING |
drug |
$835 |
IMPLANON |
drug |
$835 |
NEXPLANON |
drug |
$240 |
| † May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products. | ||
Payment Details in
| When | How Much | Related To | What For | From | Third Party Payee |
|---|---|---|---|---|---|
| Aug 15, 2014 | $6,500 | PARAGARD | Honoraria | TEVA PHARMACEUTICALS USA, INC. | |
| Jan 8, 2014 | $4,500 | OTHER | Consulting | MERCK SHARP & DOHME CORPORATION | |
| Feb 12, 2014 | $4,250 | ELAGOLIX | Consulting | ABBVIE, INC. | |
| Dec 6, 2013 | $3,600 | LECETTE | Honoraria | TEVA PHARMACEUTICALS USA, INC. | |
| Oct 15, 2015 | $3,000 | NEXPLANON | Consulting | MERCK SHARP & DOHME CORPORATION | |
| Nov 15, 2016 | $2,925 | No Listed Product |
Consulting
Additional details on this payment → Provided as part of a clinical research engagement. |
MERCK SHARP & DOHME CORPORATION | |
| Dec 20, 2013 | $2,650 | FOLLISTIM AQ WOMEN'S HEALTH NEXPLANON WOMEN'S HEALTH NUVARING WOMEN'S HEALTH |
Consulting
Additional details on this payment → This activity was conducted at the therapy area level not product-specific. The products reported are the Merck marketed products in the therapy area and they may or may not have been discussed as a part of this event. For purposes of reporting, we will report both the therapy area and product but we will only report NDCs at the product level. |
MERCK SHARP & DOHME CORPORATION | |
| Dec 20, 2013 | $2,650 | FOLLISTIM AQ WOMEN'S HEALTH NEXPLANON WOMEN'S HEALTH NUVARING WOMEN'S HEALTH |
Consulting
Additional details on this payment → This activity was conducted at the therapy area level not product-specific. The products reported are the Merck marketed products in the therapy area and they may or may not have been discussed as a part of this event. For purposes of reporting, we will report both the therapy area and product but we will only report NDCs at the product level. |
MERCK SHARP & DOHME CORPORATION | |
| Sep 23, 2013 | $2,560 | NATAZIA | Consulting | BAYER HEALTHCARE PHARMACEUTICALS INC. | |
| Jul 18, 2014 | $1,400 | NEXPLANON | Consulting | MERCK SHARP & DOHME CORPORATION | |
| Mar 25, 2014 | $1,050 | NUVARING | Consulting | MERCK SHARP & DOHME CORPORATION | |
| Aug 15, 2014 | $957 | PARAGARD | Travel and Lodging | TEVA PHARMACEUTICALS USA, INC. | |
| Dec 5, 2013 | $804 | LECETTE | Travel and Lodging | TEVA PHARMACEUTICALS USA, INC. | OHSU |
| Aug 3, 2013 | $783 | ELAGOLIX |
Travel and Lodging
Additional details on this payment → R and D on New Product |
ABBVIE, INC. | |
| Oct 6, 2016 | $779 | No Listed Product |
Travel and Lodging
Additional details on this payment → Provided as part of a research engagement. |
MERCK SHARP & DOHME CORPORATION | |
| Jun 17, 2015 | $700 | OTHER |
Consulting
Additional details on this payment → Provided as part of a consulting engagement. |
MERCK SHARP & DOHME CORPORATION | |
| Nov 7, 2014 | $637 | ELAGOLIX |
Travel and Lodging
Additional details on this payment → Clinical Investigation on New Product |
ABBVIE, INC. | |
| Jul 16, 2014 | $550 | PARAGARD | Honoraria | TEVA PHARMACEUTICALS USA, INC. | |
| Oct 3, 2015 | $541 | OTHER | Travel and Lodging | MERCK SHARP & DOHME CORPORATION | |
| May 31, 2016 | $447 | No Listed Product |
Travel and Lodging
Additional details on this payment → Provided as part of a consulting engagement. |
MERCK SHARP & DOHME CORPORATION | |
| Jul 17, 2014 | $350 | OTHER | Consulting | MERCK SHARP & DOHME CORPORATION | |
| Jun 22, 2015 | $350 | OTHER |
Consulting
Additional details on this payment → Provided as part of a consulting engagement. |
MERCK SHARP & DOHME CORPORATION | |
| Aug 14, 2014 | $282 | PARAGARD | Food and Beverage | TEVA PHARMACEUTICALS USA, INC. | |
| Oct 3, 2015 | $266 | OTHER | Travel and Lodging | MERCK SHARP & DOHME CORPORATION | |
| Oct 3, 2015 | $256 | OTHER | Travel and Lodging | MERCK SHARP & DOHME CORPORATION | |
| Nov 6, 2014 | $214 | ELAGOLIX |
Travel and Lodging
Additional details on this payment → Clinical Investigation on New Product |
ABBVIE, INC. | |
| Aug 14, 2014 | $202 | PARAGARD | Travel and Lodging | TEVA PHARMACEUTICALS USA, INC. | |
| Oct 6, 2016 | $176 | No Listed Product |
Travel and Lodging
Additional details on this payment → Provided as part of a research engagement. |
MERCK SHARP & DOHME CORPORATION | |
| Dec 12, 2013 | $157 | IMPLANON NUVARING | Travel and Lodging | MERCK SHARP & DOHME CORPORATION | |
| Dec 13, 2013 | $157 | IMPLANON NUVARING | Travel and Lodging | MERCK SHARP & DOHME CORPORATION | |
| Sep 23, 2013 | $152 | NATAZIA | Travel and Lodging | BAYER HEALTHCARE PHARMACEUTICALS INC. | |
| Nov 15, 2016 | $150 | No Listed Product |
Travel and Lodging
Additional details on this payment → Provided as part of a clinical research engagement. |
MERCK SHARP & DOHME CORPORATION | |
| Dec 20, 2013 | $150 | FOLLISTIM AQ WOMEN'S HEALTH NEXPLANON WOMEN'S HEALTH NUVARING WOMEN'S HEALTH |
Travel and Lodging
Additional details on this payment → This activity was conducted at the therapy area level not product-specific. The products reported are the Merck marketed products in the therapy area and they may or may not have been discussed as a part of this event. For purposes of reporting, we will report both the therapy area and product but we will only report NDCs at the product level. |
MERCK SHARP & DOHME CORPORATION | |
| Oct 15, 2015 | $150 | NEXPLANON | Travel and Lodging | MERCK SHARP & DOHME CORPORATION | |
| Jan 8, 2014 | $150 | OTHER | Travel and Lodging | MERCK SHARP & DOHME CORPORATION | |
| Aug 8, 2013 | $146 | ELAGOLIX |
Travel and Lodging
Additional details on this payment → R and D on New Product |
ABBVIE, INC. | |
| Aug 2, 2013 | $143 | ELAGOLIX |
Travel and Lodging
Additional details on this payment → R and D on New Product |
ABBVIE, INC. | |
| Dec 12, 2013 | $136 | IMPLANON NUVARING | Travel and Lodging | MERCK SHARP & DOHME CORPORATION | |
| Dec 14, 2013 | $136 | IMPLANON NUVARING | Travel and Lodging | MERCK SHARP & DOHME CORPORATION | |
| Dec 5, 2013 | $131 | LECETTE | Travel and Lodging | TEVA PHARMACEUTICALS USA, INC. | OHSU |
| Oct 6, 2016 | $125 | No Listed Product |
Food and Beverage
Additional details on this payment → Provided as part of a research engagement. |
MERCK SHARP & DOHME CORPORATION | |
| Dec 11, 2013 | $123 | NEXPLANON | Travel and Lodging | MERCK SHARP & DOHME CORPORATION | |
| Aug 8, 2013 | $121 | ELAGOLIX |
Food and Beverage
Additional details on this payment → R and D on New Product |
ABBVIE, INC. | |
| Nov 6, 2014 | $112 | ELAGOLIX |
Food and Beverage
Additional details on this payment → Clinical Investigation on New Product |
ABBVIE, INC. | |
| Oct 4, 2015 | $109 | OTHER | Travel and Lodging | MERCK SHARP & DOHME CORPORATION | |
| Dec 6, 2013 | $94 | LECETTE | Travel and Lodging | TEVA PHARMACEUTICALS USA, INC. | |
| Oct 3, 2015 | $84 | OTHER | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
| Nov 7, 2014 | $68 | ELAGOLIX |
Food and Beverage
Additional details on this payment → Clinical Investigation on New Product |
ABBVIE, INC. | |
| Oct 19, 2015 | $67 | ESSURE | Food and Beverage | BAYER HEALTHCARE PHARMACEUTICALS INC. | |
| Dec 13, 2013 | $66 | IMPLANON NUVARING | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
| Dec 12, 2013 | $66 | IMPLANON NUVARING | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
| Aug 15, 2014 | $63 | PARAGARD | Travel and Lodging | TEVA PHARMACEUTICALS USA, INC. | |
| Dec 11, 2013 | $57 | NEXPLANON | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
| Aug 14, 2014 | $53 | PARAGARD | Travel and Lodging | TEVA PHARMACEUTICALS USA, INC. | |
| Aug 8, 2013 | $51 | ELAGOLIX |
Food and Beverage
Additional details on this payment → R and D on New Product |
ABBVIE, INC. | |
| Nov 7, 2014 | $50 | ELAGOLIX |
Food and Beverage
Additional details on this payment → Clinical Investigation on New Product |
ABBVIE, INC. | |
| Sep 17, 2013 | $48 | ELAGOLIX |
Travel and Lodging
Additional details on this payment → R and D on New Product |
ABBVIE, INC. | |
| Aug 8, 2013 | $47 | ELAGOLIX |
Food and Beverage
Additional details on this payment → R and D on New Product |
ABBVIE, INC. | |
| Oct 7, 2016 | $45 | No Listed Product |
Food and Beverage
Additional details on this payment → Provided as part of a research engagement. |
MERCK SHARP & DOHME CORPORATION | |
| Aug 8, 2013 | $43 | ELAGOLIX |
Food and Beverage
Additional details on this payment → R and D on New Product |
ABBVIE, INC. | |
| Dec 12, 2013 | $40 | NEXPLANON | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
| Oct 7, 2016 | $40 | No Listed Product |
Food and Beverage
Additional details on this payment → Provided as part of a research engagement. |
MERCK SHARP & DOHME CORPORATION | |
| Dec 14, 2013 | $38 | IMPLANON NUVARING | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
| Oct 7, 2016 | $35 | No Listed Product |
Food and Beverage
Additional details on this payment → Provided as part of a research engagement. |
MERCK SHARP & DOHME CORPORATION | |
| Dec 13, 2013 | $32 | IMPLANON NUVARING | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
| Oct 4, 2015 | $31 | OTHER | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
| Dec 5, 2013 | $30 | No Listed Product | Food and Beverage | TEVA PHARMACEUTICALS USA, INC. | |
| Oct 4, 2015 | $29 | OTHER | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
| Aug 16, 2014 | $29 | PARAGARD | Food and Beverage | TEVA PHARMACEUTICALS USA, INC. | |
| Oct 4, 2015 | $28 | OTHER | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
| Oct 4, 2015 | $28 | OTHER | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
| Nov 7, 2014 | $24 | ELAGOLIX |
Food and Beverage
Additional details on this payment → Clinical Investigation on New Product |
ABBVIE, INC. | |
| Dec 13, 2013 | $20 | IMPLANON NUVARING | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
| Dec 12, 2013 | $19 | NEXPLANON | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
| Dec 13, 2013 | $16 | IMPLANON NUVARING | Travel and Lodging | MERCK SHARP & DOHME CORPORATION | |
| Sep 17, 2013 | $16 | ELAGOLIX |
Food and Beverage
Additional details on this payment → R and D on New Product |
ABBVIE, INC. | |
| Sep 17, 2013 | $15 | ELAGOLIX |
Food and Beverage
Additional details on this payment → R and D on New Product |
ABBVIE, INC. | |
| May 7, 2014 | $11 | REPRODUCTIVE HEALTH |
Food and Beverage
Additional details on this payment → Physicians are provided modest meals during the course of doing business with Cook Medical. The physician could be attending or presenting at an educational presentation or a product training session. We also invite physicians to dinners to give us feedback on our products or to advise us on trends in medical procedures and treatments. The total cost of a group's food and beverages at a meal are averaged across attendees. |
COOK INCORPORATED | |
| Dec 14, 2013 | $10 | IMPLANON NUVARING | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
| Oct 3, 2015 | $9 | OTHER | Food and Beverage | MERCK SHARP & DOHME CORPORATION | |
| Dec 5, 2013 | $7 | No Listed Product | Travel and Lodging | TEVA PHARMACEUTICALS USA, INC. |
See this doctor’s Open Payments page →
Note: We have made some effort to normalize the data and eliminate duplicates, but data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].